Replay
Cancel

Your 25-second video preview has ended.

to continue watching, please Log In or Register:


Log in / Register

Interpreting the Data: Isotretinoin and Monthly Monitoring

In this edition of Derm Insider, host Neal Bhatia, MD talks to James Q. Del Rosso, DO and Hilary Baldwin, MD about a recent study suggesting monthly blood test monitoring for patients taking isotretinoin may not be necessary after two months if there is no abnormality. Drs. Del Rosso and Baldwin discuss the potential downside to this—from the outliers who may not show abnormalities until later to third-parties who could interpret the data to deny coverage for blood work dermatologists may still want to order. They also share insight into the pipeline for new rosacea and acne treatments.

More Videos in this Series